AppYea Secures US Patent for Innovative Sleep Apnea Detection Using Speech Analysis

New Patent Promises Affordable and Convenient Sleep Apnea Diagnostics; Market Projected to Reach US$ 9.27 Billion by 2033

GAN YAVNE, ISRAEL / ACCESSWIRE / August 28, 2023 / SleepX, a subsidiary of AppYea Inc. (OTC:APYP), focusing on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring, announces it has been granted a patent (US 11,672,472 B2) by the United States Patent and Trademark Office, titled: “Methods and Systems for Estimation of Obstructive Sleep Apnea Severity in Wake Subjects by Multiple Speech Analyses.” The patent extends through November 2038 and provides broad coverage in the field of sleep apnea monitoring. 

According to Future Market Insights Inc. ( August 22, 2023), Technological Breakthroughs Stoke Sleep Apnea Diagnostic Systems Market Set to Reach US$ 9.27